NEW MJ NEWS

Cresco Labs to Report First Quarter 2022 Financial Results on May 18, 2022

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the first quarter ended March 31st, 2022 on Wednesday May 18th, 2022 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs First Quarter 2022 Earnings Conference Call
Date: Wednesday May 18th, 2022
Time: 8:30 am EDT
Webcast: Link
Dial-in: 1-844-200-6205 (US Toll Free) 1-833-950-0062 (CDN Toll Free), 1-646-904-5544 (US Local), +1 929-526-1599 (Other)
Access Code: 017231

Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs

Instagram: Cresco Labs

Twitter: Cresco Labs

View source version on businesswire.com: https://www.businesswire.com/news/home/20220506005061/en/

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GW Pharmaceuticals (GWPH) Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019

– Epidiolex U.S. Q2 net sales of $68.4 million – – Positive…

The Green Organic Dutchman (TGOD.TO) (TGODF) Provides Update on Spin-off Transaction

The Green Organic Dutchman Provides Update on Spin-off Transaction and Announces Intention…

Reliq Health Technologies Inc. (RQHTF) Announces Upcoming Shareholder Update Webinar

Reliq Health Technologies, Inc. Announces Upcoming Shareholder Update Webinar Reliq Health Technologies…

Future Farm Technologies Inc. (FFRMF ) Announces Scott McDermid to Manage and Build LED Canada Division

Future Farm Announces Scott McDermid to Manage and Build LED Canada Division…